Funding for this research was provided by:
University of Gothenburg
Received: 2 March 2022
Accepted: 21 July 2022
First Online: 2 August 2022
: The study was approved by the Regional Ethics Review Board in Gothenburg (Dnr. 286–18) and conducted according to the Declaration of Helsinki. Informed consent from the patients was waived due to the retrospective study design.
: Not applicable.
: Kristjan Karason has received lecture fees from Orion Pharma and Abbot. None of the remaining authors have any conflicts of interest ties to disclose.